KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Tax Provisions: 2017-2024

Historic Tax Provisions for Sarepta Therapeutics (SRPT) over the last 8 years, with Dec 2024 value amounting to $25.8 million.

  • Sarepta Therapeutics' Tax Provisions rose 799.76% to $64.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $84.5 million, marking a year-over-year increase of 459.95%. This contributed to the annual value of $25.8 million for FY2024, which is 60.71% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported Tax Provisions of $25.8 million as of FY2024, which was up 60.71% from $16.0 million recorded in FY2023.
  • Over the past 5 years, Sarepta Therapeutics' Tax Provisions peaked at $25.8 million during FY2024, and registered a low of -$168,000 during FY2021.
  • In the last 3 years, Sarepta Therapeutics' Tax Provisions had a median value of $16.0 million in 2023 and averaged $18.7 million.
  • In the last 5 years, Sarepta Therapeutics' Tax Provisions crashed by 112.84% in 2021 and then spiked by 8,514.88% in 2022.
  • Sarepta Therapeutics' Tax Provisions (Yearly) stood at $1.3 million in 2020, then crashed by 112.84% to -$168,000 in 2021, then surged by 8,514.88% to $14.1 million in 2022, then increased by 13.49% to $16.0 million in 2023, then spiked by 60.71% to $25.8 million in 2024.